Drug intelligence / Profile preview

Bamboo Myxin

Development stage: Preclinical
Lead developer: Beijing University of Chinese Medicine East Hospital
Modality: Small Molecules
Administration: Topical

Overview

Bamboo Myxin is a pharmaceutical drug formulated as an ointment, with its core component being an ethanol extract of Bamboo Myxin (竹红菌). It is primarily indicated for the treatment of vulva white lesion, and also used for conditions such as keloids, vulvar itching, and vulvitis. The drug functions as a photochemotherapeutic agent, requiring activation by light exposure (e.g., sunlight, fluorescent lamp, or infrared lamp) after topical application to exert its therapeutic effects. Its mechanism involves regulating local tissue metabolic function and promoting the recovery of the affected skin's color, cellular structure, and characteristics.

Other names: Bamboo myxin ointment竹红菌素软膏

Beyond the preview

Go deeper on Bamboo Myxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bamboo Myxin.

Explore the full profile